Filing Details

Accession Number:
0001213900-19-016514
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-22 16:30:33
Reporting Period:
2019-08-20
Accepted Time:
2019-08-22 16:30:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1711754 Inmune Bio Inc. INMB Biological Products, (No Disgnostic Substances) (2836) 475205835
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1767084 Scott Juda C/O Inmune Bio Inc.,
1200 Prospect Street, Suite 525
La Jolla CA 92037
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-20 2,500 $6.00 25,000 No 4 P Direct
Common Stock Acquisiton 2019-08-21 2,500 $6.00 27,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The Reporting Person purchased 2,500 shares of the Issuer's common stock in an open market transaction on August 20, 2019 and 2,5000 shares of the Issuer's common stock in an open market transaction on August 21, 2019.
  2. The Reporting Person's shares are held by Fossick Capital LP ("Fossick"), a limited partnership. The Reporting Person holds all voting and dispositive control over the Issuer's shares of common stock held by Fossick.